2026 Q3 Portfolio Activity
In 2026 Q3, BVF INC/IL maintained a portfolio of 48 distinct positions. The most significant new addition was PYXIS ONCOLOGY INC, now representing 0.91% of the total fund value. They heavily accumulated shares in TYRA BIOSCIENCES INC, increasing the position by 185.6%. Conversely, BVF INC/IL completely exited their position in XOMA ROYALTY CORPORATION.
Position History
hover any row below to update
Loading…
Total Positions
48
Quarter
2026 Q3
Top Holding
RVMD (16.6%)
Top 10 Concentration
66.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-48 of 48
BVF INC/IL Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 16.61% | 14.20% |
#1
Prev: #1
|
6.5 |
—
|
-504,600 | -17.0% |
P
S
|
2,460,560 | $505,054,546 | 2020 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 14.24% | 11.35% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
3,872,052 | $432,856,693 | 2020 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 6.68% | 5.95% |
#3
2
Prev: #5
|
4.7 |
—
|
no change | no change |
P
S
|
8,650,158 | $203,105,710 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 6.16% | 7.97% |
#4
Prev: #4
|
4.0 |
—
|
no change | no change |
P
S
|
16,001,284 | $187,215,023 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XNCR
XENCOR INC
|
Healthcare | 5.11% | 2.94% |
#5
4
Prev: #9
|
3.0 |
—
|
-906,686 | -12.7% |
P
S
|
6,227,034 | $155,364,498 | 2013 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 4.25% | 4.27% |
#6
1
Prev: #7
|
2.2 |
—
|
-257,068 | -10.8% |
P
S
|
2,134,007 | $129,203,454 | 2007 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 3.79% | 2.89% |
#7
3
Prev: #10
|
4.0 |
—
|
692,396 | 32.1% |
P
S
|
2,847,100 | $115,364,492 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 3.09% | 2.13% |
#8
9
Prev: #17
|
3.7 |
—
|
1,061,411 | 41.7% |
P
S
|
3,608,968 | $93,833,168 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 3.03% | 1.21% |
#9
13
Prev: #22
|
4.2 |
—
|
2,739,690 | 185.6% |
P
S
|
4,215,886 | $92,201,427 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 3.02% | 2.44% |
#10
4
Prev: #14
|
1.7 |
—
|
-185,000 | -5.1% |
P
S
|
3,464,142 | $91,765,122 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 2.90% | 2.68% |
#11
1
Prev: #12
|
2.2 |
—
|
no change | no change |
P
S
|
5,750,683 | $88,272,984 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.77% | 4.62% |
#12
6
Prev: #6
|
1.1 |
—
|
-675,397 | -20.1% |
P
S
|
2,691,426 | $84,160,891 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 2.75% | 2.63% |
#13
Prev: #13
|
1.6 |
—
|
-65,640 | -9.8% |
P
S
|
607,149 | $83,744,062 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 2.36% | 2.37% |
#14
1
Prev: #15
|
0.9 |
—
|
-1,755,661 | -20.8% |
P
S
|
6,690,108 | $71,651,057 | 2017 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ACIU
AC IMMUNE SA
|
Healthcare | 1.71% | 1.21% |
#15
6
Prev: #21
|
1.7 |
—
|
no change | no change |
P
S
|
19,822,436 | $51,934,782 | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.68% | 2.76% |
#16
5
Prev: #11
|
1.2 |
—
|
-184,308 | -4.1% |
P
S
|
4,276,578 | $51,019,576 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ENTX
ENTERA BIO LTD
|
Healthcare | 1.63% | 0.11% |
#17
25
Prev: #42
|
3.7 |
—
|
14,627,893 | 603.2% |
P
S
|
17,052,893 | $49,623,919 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 1.51% | 1.69% |
#18
Prev: #18
|
1.6 |
—
|
no change | no change |
P
S
|
5,295,893 | $45,756,516 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.48% | 1.27% |
#19
1
Prev: #20
|
2.6 |
—
|
344,827 | 12.5% |
P
S
|
3,093,590 | $45,135,478 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 1.36% | 0.98% |
#20
6
Prev: #26
|
1.5 |
—
|
no change | no change |
P
S
|
2,879,289 | $41,202,626 | 2020 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.23% | 1.05% |
#21
3
Prev: #24
|
1.0 |
—
|
-63,554 | -4.9% |
P
S
|
1,230,909 | $37,284,234 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.15% | 1.27% |
#22
3
Prev: #19
|
1.0 |
—
|
-420,009 | -4.8% |
P
S
|
8,278,164 | $35,016,634 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 1.15% | 3.16% |
#23
15
Prev: #8
|
0.5 |
—
|
-648,801 | -61.4% |
P
S
|
407,226 | $34,809,678 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 1.14% | 0.49% |
#24
9
Prev: #33
|
3.0 |
—
|
1,000,000 | 40.0% |
P
S
|
3,500,000 | $34,580,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 0.91% | — |
#25
Prev: #—
|
3.9 |
—
|
11,826,140 | — |
NEW
|
11,826,140 | $27,554,906 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABSI
ABSCI CORPORATI...
|
Healthcare | 0.84% | 0.70% |
#26
4
Prev: #30
|
1.3 |
—
|
no change | no change |
P
S
|
2,361,674 | $25,435,229 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.81% | 0.63% |
#27
5
Prev: #32
|
1.3 |
—
|
no change | no change |
P
S
|
28,165,000 | $24,506,367 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 0.77% | 0.76% |
#28
Prev: #28
|
1.3 |
—
|
no change | no change |
P
S
|
3,000,000 | $23,310,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FHTX
FOGHORN THERAPE...
|
Healthcare | 0.69% | 0.73% |
#29
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
5,842,000 | $20,855,940 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.66% | 1.06% |
#30
7
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
1,251,788 | $20,166,305 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QTTB
Q32 BIO INC
|
Healthcare | 0.64% | 0.77% |
#31
4
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
2,350,000 | $19,434,500 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.61% | — |
#32
Prev: #—
|
3.7 |
—
|
10,046,206 | — |
NEW
|
10,046,206 | $18,585,481 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 0.52% | 0.63% |
#33
2
Prev: #31
|
1.2 |
—
|
no change | no change |
P
S
|
6,293,282 | $15,922,003 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.50% | 2.16% |
#34
18
Prev: #16
|
0.2 |
—
|
-920,312 | -79.8% |
P
S
|
233,300 | $15,271,818 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.46% | 0.98% |
#35
10
Prev: #25
|
0.2 |
—
|
-1,168,139 | -56.3% |
P
S
|
907,406 | $13,910,534 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OKUR
ONKURE THERAPEU...
|
Healthcare | 0.36% | 0.38% |
#36
2
Prev: #34
|
2.6 |
—
|
809,500 | 25.0% |
P
S
|
4,045,278 | $11,023,383 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 0.23% | 0.30% |
#37
2
Prev: #35
|
1.1 |
—
|
no change | no change |
P
S
|
765,295 | $7,117,244 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
TCGX ACQUISITIO...
|
|
Unknown | 0.21% | — |
#38
Prev: #—
|
3.6 |
—
|
500,000 | — |
NEW
|
500,000 | $6,255,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.19% | — |
#39
Prev: #—
|
3.6 |
—
|
500,000 | — |
NEW
|
500,000 | $5,920,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.18% | 0.14% |
#40
1
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
500,000 | $5,355,000 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
MOLN
MOLECULAR PARTN...
|
Healthcare | 0.17% | 0.13% |
#41
1
Prev: #40
|
1.1 |
—
|
no change | no change |
P
S
|
1,353,968 | $5,185,697 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 0.17% | 0.17% |
#42
5
Prev: #37
|
1.1 |
—
|
no change | no change |
P
S
|
1,110,002 | $5,083,809 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 0.15% | 0.27% |
#43
7
Prev: #36
|
0.1 |
—
|
-657,118 | -29.4% |
P
S
|
1,576,624 | $4,572,210 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 0.08% | 0.07% |
#44
1
Prev: #43
|
1.0 |
—
|
no change | no change |
P
S
|
686,040 | $2,531,488 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TCRX
TSCAN THERAPEUT...
|
Healthcare | 0.06% | 0.14% |
#45
7
Prev: #38
|
1.0 |
—
|
no change | no change |
P
S
|
5,564,290 | $1,749,969 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
N/A
ENGENE THERAPEU...
|
|
Unknown | 0.01% | 0.01% |
#46
2
Prev: #44
|
1.0 |
—
|
no change | no change |
P
S
|
945,402 | $189,175 | — | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.00% | 0.13% |
#47
6
Prev: #41
|
0.0 |
—
|
-314,549 | -92.6% |
P
S
|
25,000 | $47,250 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XOMA
XOMA ROYALTY CO...
|
Healthcare | 0.00% | 8.25% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-7,593,303 | -100.0% |
CLOSED
|
— | $— | 2016 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-48 of 48 holdings